Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

This study has been completed.
Information provided by (Responsible Party):
Manuela Merli, University of Roma La Sapienza Identifier:
First received: October 8, 2009
Last updated: June 19, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)